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Airborne emissions from hot asphalt contain mixtures of polycyclic aromatic hydrocarbons
(PAHs), including several carcinogens. We investigated urinary biomarkers of three PAHs,
namely naphthalene (Nap), phenanthrene (Phe), and pyrene (Pyr) in 20 road-paving workers
exposed to hot asphalt and in 6 road milling workers who were not using hot asphalt (reference
group). Our analysis included baseline urine samples as well as postshift, bedtime, and morning
samples collected over three consecutive days. We measured unmetabolized Nap (U-Nap) and
Phe (U-Phe) as well as the monohydroxylated metabolites of Nap (OH-Nap), Phe (OH-Phe),
and Pyr (OH-Pyr) in each urine sample. In baseline samples, no significant differences in bio-
marker levels were observed between pavers and millers, suggesting similar background expo-
sures. In postshift, bedtime, and morning urine samples, the high pairwise correlations
observed between levels of all biomarkers suggest common exposure sources. Among pavers,
levels of all biomarkers were significantly elevated in postshift samples, indicating rapid uptake
and elimination of PAHs following exposure to hot asphalt (biomarker levels were not elevated
among millers). Results from linear mixed-effects models of levels of U-Nap, U-Phe, OH-Phe,
and OH-Pyr across pavers showed significant effects of work assignments with roller operators
having lower biomarker levels than the other workers. However, no work-related effect was
observed for levels of OH-Nap, apparently due to the influence of cigarette smoking. Biological
half-lives, estimated from regression coefficients for time among pavers, were 8 h for U-Phe,
10 h for U-Nap, 13 h for OH-Phe and OH-Pyr, and 26 h for OH-Nap. These results support
the use of U-Nap, U-Phe, OH-Phe, and OH-Pyr, but probably not OH-Nap, as short-term
biomarkers of exposure to PAHs emanating from hot asphalt.
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INTRODUCTION
Asphalt (also referred to as bitumen) is a by-product
of petroleum refining that is widely used to pave
roads. Road-paving workers are exposed to emis-
sions from hot asphalt that contain polycyclic aro-
matic hydrocarbons (PAHs), some of which are
carcinogens (IARC, 1987). Although epidemiologic
evidence points to increased cancer risks among
asphalt-exposed workers (Partanen and Boffetta,
1994; Boffetta et al., 1997; Hooiveld et al., 2002;
Burstyn et al., 2003; Randem et al., 2004), the
dose–response relationship is not well defined
(Chiazze et al., 1991; NIOSH, 2000). This inability
to characterize the asphalt/PAH dose–response rela-
tionship stems, in part, from the lack of data related
to levels of PAH exposures from airborne and dermal
routes among road-paving workers (Chiazze et al.,
1991; NIOSH, 2000).




To better understand asphalt exposures and related
health effects, efforts have focused on biomarkers
of exposure, such as unmetabolized PAHs and PAH
metabolites in urine. These short-term biomarkers
represent internal doses of PAHs received from all
routes during the current work shift. Indeed, a urinary
metabolite of pyrene (Pyr) [namely 1-hydroxypyrene
(OH-Pyr)] has been shown to reflect recent asphalt
exposures (Jongeneelen et al., 1988; McClean et al.,
2004b; Campo et al., 2006b) and is regarded as a ‘gold
standard’ for a general assessment of PAH exposures.
More recently, urinary levels of unmetabolized naph-
thalene (Nap) and phenanthrene (Phe) (designated as
U-Nap and U-Phe, respectively) (Campo et al.,
2006a; Buratti et al., 2007), and of hydroxylated
Nap and Phe metabolites (Väänänen et al., 2003; Vää-
nänen et al., 2006; Buratti et al., 2007), have been
shown to reflect recent exposures to asphalt emis-
sions. (Hereafter, the sum of 1- and 2-hydroxynaph-
thalene will be referred to as ‘OH-Nap’ and the sum
of 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene will be
referred to as ‘OH-Phe’). However, the rates of uptake
and elimination of these biomarkers have not been
well characterized, and the influences of covariates,
such as job, smoking status, and hydration level, have
not been thoroughly examined as potential confound-
ers or modifiers of urinary analyte levels.
In a previous analysis of highway construction
workers’ exposures to polycyclic aromatic com-
pounds (PACs, a group of aromatic hydrocarbons
containing primarily PAHs and heterocyclic com-
pounds with four or more rings), 26 workers in the
Greater Boston area of the USA were monitored dur-
ing a workweek to evaluate the extent of PAC expo-
sure from the air and dermal routes and the impact
of PAC exposures on urinary levels of OH-Pyr
(McClean et al., 2004a,b). Results showed that meas-
urements of PACs in the air (representing inhalation
exposure) and of dermal patch samples (representing
dermal exposure) varied significantly according to
the work assignment (McClean et al., 2004a). Addi-
tionally, results showed that urinary OH-Pyr concen-
trations in workers were significantly affected by
inhalation of and dermal contact with asphalt emis-
sions (McClean et al., 2004b). The purpose of this
study was to measure the levels of U-Nap, U-Phe,
OH-Nap, OH-Phe and OH-Pyr in these same urine
samples to identify additional useful surrogates of
PAC/PAH exposure and to clarify the effects of po-
tential confounders on urinary analyte levels. Here,
we pay particular attention to correlations across
measured urinary analytes, the rates of elimination
of analytes from the body, and the effects on the sub-
jects’ urinary analyte levels due to the workday, work
assignment, level of hydration (as measured by uri-
nary creatinine), and smoking status. Because re-
peated samples of urine were collected from the
workers over time, we applied mixed-effects models
for statistical analysis, given the advantages of these
models for estimating effects with correlated data
(i.e. urinary analyte levels measured at different
times from the same workers are positively corre-
lated) (Rappaport and Kupper, 2008).
METHODS
Study population and design
Many details of this study have been published
(McClean et al., 2004a,b). In the current investigation,
we consider 26 male highway construction workers re-
siding in the Greater Boston area of the USA. Workers
were recruited with informed consent according to
a protocol approved for the protection of human sub-
jects. Twenty pavers were involved with the applica-
tion of hot asphalt on road surfaces and six millers
were involved in removal of old road materials includ-
ing asphalt. (Since the millers did not work with hot
asphalt, they were included in this analysis as a refer-
ence group). The pavers were subdivided according to
their work assignments, namely, paver operators (three
workers), screedmen (five workers), rakers (eight
workers), and roller operators (four workers). Paver
operators drove the paving machines, screedmen were
positioned on a platform at the rear of the paving ma-
chines, rakers followed closely behind the paving ma-
chines to fill holes, and rolling operators drove rolling
machines to smooth and compact the asphalt.
Over each of two or three consecutive days, start-
ing at the beginning of the workweek, urine samples
were collected before work (morning), after work
(postshift), and at bedtime. Morning samples from
the first day of the workweek were treated as baseline
samples. Overall, seven urine samples were collected
from each miller (two sampling days), and 10 urine
samples were collected from each paver (three sam-
pling days). Urine was collected in sterilized poly-
propylene containers and stored at 20C for up
to 7 years prior to analysis. Smoking status was ob-
tained by questionnaire (6 smokers; 20 nonsmokers).
Creatinine levels were determined using a colorimet-
ric procedure (Sigma, 1984).
Measurement of urinary naphthalene (U-Nap) and
phenanthrene (U-Phe)
Naphthalene and Phe were extracted from 0.7 ml of
urine using head space solid-phase microextraction
and analyzed using gas chromatography–mass spec-
trometry, as previously described (Waidyanatha et al.,
2003; Sobus et al., 2009). Standard curves were pre-
pared by spiking Nap, Phe, (2H8)naphthalene, and
(2H10)phenanthrene (internal standards) into pooled
urine collected from nonsmoking volunteer subjects
from our laboratory. Quantitation of U-Nap and U-Phe
in the samples was based on response ratios of analytes
with respect to the corresponding internal standards.
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The estimated limit of detection for both U-Nap and U-
Phe was 0.40 ng l1 (Sobus et al., 2009). The estimated
coefficients of variation for U-Nap and U-Phe were 0.25
and 0.26, respectively (Sobus et al., 2009).
Analysis of urinary PAH metabolites
The hydroxylated metabolites, OH-Nap, OH-Phe,
and OH-Pyr, were measured as described elsewhere
(Onyemauwa et al., 2009). Briefly, 3-ml aliquots of
urine were digested using b-glucuronidase/arylsulfa-
tase (Roche Diagnostics, Indianapolis, IN, USA),
and the hydroxylated metabolites were purified using
solid-phase extraction (EnvirElute PAH cartridges,
Varian, Palo Alto, CA, USA) and analyzed via liquid
chromatography–tandem mass spectrometry with
a Surveyor LC system (ThermoElectron, San Jose,
CA, USA) and a Finnigan TSQ Quantum Ultra triple
quadrupole mass spectrometer (ThermoElectron).
A ThermaGold C18 column (3 lm, 150 mm  2.1
mm) (ThermoFisher Scientific, Waltham, MA, USA)
was used for separation with a flow rate of 250 ll
min1. Methanol and water were used as the mobile
phase with a gradient of 55–81.8% methanol over 25
min. The following parent-to-product ion transitions
were monitored: m/z 143.02–115.09 for 1- and
2-OH-Nap, m/z 193.02–165.08 for 1-, 2-, 3-, 4-, and
9-OH-Phe, and m/z 217.02–189.08 for 1-OH-Pyr.
Calibration curves were prepared by adding standards
and a mixture of isotopically labeled internal stand-
ards [(2H8)1-hydroxynaphthalene, (
13C6)3-hydroxy-
phenanthrene, and (2H8)1-hydroxypyrene] into
pooled urine collected from nonsmoking laboratory
volunteer subjects. Quantitation was based on the re-
sponse ratio of each analyte with respect to the corre-
sponding internal standard. The limits of quantitation
(based on a signal-to-noise ratio of 10) for the urinary
PAH metabolites were 0.001 lg l1 for 2-OH-Nap;
0.002lg l1 for (2 þ 3)-OH-Phe (these isomers could
not be chromatographically separated and were quanti-
fied together); 0.005 lg l1 for 1-OH-Phe, 4-OH-Phe,
9-OH-Phe, and 1-OH-Pyr; and 0.010 lg l1 for 1-
OH-Nap (Onyemauwa et al., 2009). The estimated
coefficients of variation for these analytes ranged
from 0.053 to 0.27 (Onyemauwa et al., 2009).
Statistical methods
For all statistical analyses, levels of 1- and 2-OH-
Nap and levels of 1-, 2-, 3-, 4-, and 9-OH-Phe were
summed and are presented here as OH-Nap and
OH-Phe, respectively. Urinary analyte data were
evaluated using SAS statistical software (v. 9.1,
SAS Institute, Cary, NC, USA) after natural log-
transformation to satisfy normality assumptions and
to remove heteroskedasticity. Due to the repeated
measures sampling design, linear mixed-effects mod-
els (Proc MIXED) were used to estimate correlation
coefficients between analytes according to Hamlett
et al. (2003). To test the effects of job (pavers and
millers) and urine collection time (baseline, post-
shift, bedtime, and morning) on analyte levels, base-
line data (one measurement per subject) were
analyzed using general linear models (Proc GLM),
and postshift, bedtime, and morning data (repeated
measures) were assessed using mixed models (Proc
MIXED). A P-value , 0.05 was considered signifi-
cant (two-tailed test). Mixed models were also used
to assess covariate influence [creatinine (g l1), time
(h postshift), work assignment, workday, and smok-
ing status (current smoker versus nonsmoker)] on
analyte levels. Rather than dividing each analyte con-
centration by the corresponding creatinine concen-
tration prior to statistical analysis, the creatinine
concentration was included as an independent vari-
able in the multivariable models to allow analyte
levels and other covariates to be simultaneously ad-
justed for variations in urine dilution (Barr et al.,
2005). To assess time effects, postshift measure-
ments were assigned values of 0 h, and bedtime and
morning measurements were assigned values repre-
senting the times after the postshift urine samples
were collected [bedtime median 5 6.00 h (range:
2.50–14.3 h), morning median 5 15.3 h (range:
11.819.1 h)]. Elimination rate constants (k) and bio-
logical half-lives (T1/2 5 0.693/k) were estimated
using the regression coefficients for time after adjust-
ing for significant covariates. Multivariable mixed
models were evaluated using manual backwards step-
wise elimination at a significance level of a 5 0.10.
Bayesian Information Criterion (BIC) diagnostic val-
ues were used to select between competing models. A
compound symmetry covariance matrix was used in
all mixed-effects models. This covariance structure
generally yielded the lowest BIC values compared
to those from other homogeneous autoregressive
and heterogeneous autoregressive matrices.
RESULTS
Descriptive statistics and correlation analysis for
urinary analytes
Table 1 lists geometric means (GMs), geometric
standard deviations (GSDs), and numbers of observa-
tions for each analyte measured in urine specimens
collected at different times from pavers and millers.
As expected, the GMs of urinary analyte levels were
greater for pavers than for millers. Among pavers,
OH-Nap was the most abundant biomarker (GM 5
17 600 ng l1) followed by OH-Phe (GM 5
7930 ng l1), OH-Pyr (GM 5 2110 ng l1), U-Nap
(GM 5 92.0 ng l1), and finally U-Phe (GM 5
70.8 ng l1). Figure 1 shows a correlation matrix
for all analytes (in log scale). Significant pairwise
correlations were observed in all cases, suggesting
common exposure sources for these urinary PAH
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Table 1. Descriptive statistics for urinary analytes (ng l1) measured in road pavers and millers
Analyte Job Baseline Postshift Bedtime Morning
n GM (GSD) n GM (GSD) n GM (GSD) n GM (GSD)
U-Nap Pavers 20 29.6 (2.31) 58 92.0*** (2.13) 54 48.7** (2.28) 56 36.8 (2.14)
Millers 6 36.1 (1.43) 11 34.4 (2.13) 9 31.2 (1.70) 9 26.4 (1.51)
U-Phe Pavers 20 9.16 (3.12) 58 70.8*** (2.61) 54 32.4*** (3.46) 56 13.5 (3.40)
Millers 6 14.9 (3.12) 11 24.7 (3.34) 9 12.8 (3.51) 9 6.56 (2.11)
OH-Nap Pavers 19 9200 (3.42) 55 17600*** (2.45) 52 12500* (2.94) 54 10500 (2.87)
Millers 6 11000 (2.16) 11 9510 (2.93) 9 4580 (3.11) 9 3830 (2.86)
OH-Phe Pavers 19 1640 (2.26) 55 7930*** (2.14) 52 4750*** (2.73) 54 2400** (2.20)
Millers 6 1380 (1.89) 11 1850 (2.39) 9 1690 (2.68) 9 1240 (2.36)
OH-Pyr Pavers 19 375 (3.43) 55 2110*** (2.63) 52 1130*** (4.02) 54 708** (3.63)
Millers 6 323 (3.79) 11 536* (3.97) 9 484 (3.01) 9 367 (3.64)
n, number of observations; U-Nap, urinary naphthalene; U-Phe, urinary phenanthrene; OH-Nap, sum of monohydroxylated
metabolites of naphthalene; OH-Phe, sum of monohydroxylated metabolites of phenanthrene; OH-Pyr, 1-hydroxypyrene.
***Significantly different than baseline level (P-value , 0.0001); **Significantly different than baseline level (P-value , 0.05);
*Marginally different than baseline level (P-value , 0.10).
Fig. 1. Pairwise correlations between urinary analytes (in log scale) for milling and paving workers. n (number of paired
observations) 5 223 for U-Nap versus U-Phe and 215 for all other comparisons. (Legend: U-Nap, urinary naphthalene; U-Phe,
urinary phenanthrene; OH-Nap, sum of monohydroxylated metabolites of naphthalene; OH-Phe, sum of monohydroxylated
metabolites of phenanthrene; and OH-Pyr, 1-hydroxypyrene).
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biomarkers. The strongest correlations were observed
between OH-Phe and OH-Pyr (r 5 0.90), U-Phe and
OH-Phe (r 5 0.84), and U-Nap and U-Phe
(r 5 0.80). Weaker correlations were observed when
comparing OH-Nap to all other analytes (r  0.53).
We note that the levels of OH-Pyr measured here were
highly correlated with the original OH-Pyr measure-
ments reported by McClean et al. (2004b) (r 5 0.89).
Furthermore, a regression coefficient of 1.02 (standard
error 5 0.044) was observed when OH-Pyr measure-
ments from this study were regressed on those from the
original study in log scale (McClean et al., 2004b).
These results, combined with the fact that the overall
GM OH-Pyr levels were nearly identical between
studies [this study: GM 5 1130 ng l1 versus original
study: GM 5 1100 ng l1 (based upon 194 common
observations)], indicate good agreement between lab-
oratories and that the prolonged period of storage
(7 years) prior to our laboratory analyses did not
appreciably affect measurements.
Effects of job and time of urine collection
In baseline urine samples, results from general
linear models showed no significant effect of job on
urinary analyte levels (P-value 0.37). When we con-
sidered all other collection times (i.e. postshift, bed-
time, and morning), significant effects of job were
observed after adjusting for time of urine collection
(P-value , 0.05 for U-Nap, U-Phe, OH-Phe, and
OH-Pyr; P-value 5 0.07 for OH-Nap). Table 1 dis-
plays job-specific GM levels of urinary analytes for
each urine collection time. Among millers, postshift,
bedtime, and morning analyte levels were not signifi-
cantly higher than baseline levels (P-value  0.09).
However, among pavers, levels of OH-Phe and
OH-Pyr were significantly higher than baseline levels
in postshift samples (P-value , 0.0001), bedtime
samples (P-value , 0.0001), and morning samples
(P-value 0.02), and levels of U-Nap and U-Phe were
significantly elevated in postshift samples (P-value ,
0.0001) and bedtime samples (P-value  0.005). For
OH-Nap, the increase in postshift levels over baseline
levels was highly significant (P-value , 0.0001),
while the increase in bedtime levels over baseline
levels was marginally significant (P-value 5 0.07).
Elimination rates and effects of hydration level,
work assignment, workday, and smoking status
Biomarker levels among pavers were investigated
with linear mixed-effects models to estimate elimina-
tion rate constants and to test for differences associated
with hydration level (as indicated by levels of urinary
creatinine), work assignments, workday, and smoking
status. [Observations from millers were not included in
this analysis because preliminary results showed no ef-
fect of occupational exposure on analyte levels (see
Table 1). Additionally, as morning measurements of
U-Nap, U-Phe, and OH-Nap from pavers were not sig-
nificantly elevated above baseline levels (see Table 1),
only postshift and bedtime measurements were in-
cluded in the final models]. Table 2 shows estimated
parameters from final models for each analyte. In each
case, a significant positive effect of urinary creatinine
was observed (P-value , 0.0001), indicating in-
creased analyte levels with decreased urine volume.
After adjusting for creatinine concentration, a signifi-
cant negative effect of time was observed for each an-
alyte (P-value  0.01), indicating a decrease in
analyte levels from the time of postshift urine collec-
tion to bedtime. Using estimated elimination rate con-
stants (as indicated by the negative regression
coefficients for time in the models), the correspond-
ing half-lives (T1/2 values) and 95% confidence inter-
vals were estimated to be 7.70 h (5.17 h, 15.1 h) for
U-Phe, 10.2 h (7.07 h, 17.8 h) for U-Nap, 13.3 h
(7.79 h, 46.2 h) for OH-Pyr, 13.6 h (9.00 h, 27.7 h)
for OH-Phe, and 25.7 h (14.1 h, 116 h) for OH-Nap.
After adjusting for time, significant or marginally
significant effects of work assignment were observed
for U-Nap, U-Phe, OH-Phe, and OH-Pyr (P-value ,
0.09). These results (shown in Table 2) indicate that
analyte levels were lower in roller operators compared
to paver operators, screedmen, and rakers. Specifi-
cally, results from the models suggest that U-Phe
and OH-Phe levels in roller operators were signifi-
cantly lower than in paver operators, screedmen, and
rakers (P-value , 0.05), and that U-Nap and OH-
Pyr levels in roller operators were significantly lower
than in screedmen and rakers (P-value , 0.05) and
marginally lower than in paver operators (P-value ,
0.15). When roller operators were removed from the
models, no significant effect of work assignment
was observed across paver operators, screedmen, and
rakers (P-value  0.05). Figure 2A–E shows baseline
analyte levels along with postshift and bedtime ana-
lyte levels over three consecutive days. Because ana-
lyte levels did not differ significantly across paver
operators, screedmen, and rakers, the mean (logged)
values of these combined work groups, along with
the mean values of roller operators, are displayed.
The differences in analyte levels between roller oper-
ators and all other pavers are apparent for all analytes
except OH-Nap (Fig. 2C). Increases in analyte levels
over each workday were also observed (P-value ,
0.10; Table 2) for U-Nap (Fig. 2A), OH-Phe
(Fig. 2D), and OH-Pyr (Fig. 2E). While no work as-
signment or workday effect was observed for OH-
Nap, a highly significant smoking effect was found
on levels of OH-Nap, with smokers having higher an-
alyte levels than nonsmokers (Table 2). No other an-
alytes were significantly affected by smoking status.
DISCUSSION
Although some relationships between airborne ex-
posures to PAHs and urinary PAH biomarkers have
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Table 2. Results from the linear mixed-effects models evaluating urinary analytes in paving workers
Parameters U-Nap U-Phe OH-Nap OH-Phe OH-Pyr
Estimate (SE) P-value Estimate (SE) P-value Estimate (SE) P-value Estimate (SE) P-value Estimate (SE) P-value
Fixed effects
Intercept 3.04 (0.331) ,0.0001 2.03 (0.413) 0.0002 9.68 (0.317) 0.0001 6.91 (0.288) ,0.0001 5.25 (0.457) ,0.0001
Creatinine (g l1) 0.550 (0.111) ,0.0001 0.652 (0.159) ,0.0001 0.554 (0.085) ,0.0001 0.639 (0.100) ,0.0001 0.830 (0.145) ,0.0001
Time (h) 0.068 (0.015) ,0.0001 0.090 (0.022) 0.0001 0.027 (0.011) 0.01 0.051 (0.013) 0.0002 0.052 (0.019) 0.007
Work assignment 0.09 0.003 0.3 ,0.0001 0.02
Paver operator 0.724 (0.379) 0.918 (0.440) 0.141 (0.360) 0.960 (0.316) 0.857 (0.537)
Screedman 0.782 (0.335) 1.33 (0.390) 0.565 (0.324) 1.25 (0.280) 1.21 (0.475)
Raker 0.648 (0.306) 1.26 (0.356) 0.343 (0.303) 1.29 (0.257) 1.39 (0.435)
Roller operator 0 (ref.) 0 (ref.) 0 (ref.) 0 (ref.) 0 (ref.)
Workday 0.004 NS NS 0.02 0.09
Day 1 0.398 (0.125) 0.305 (0.117) 0.362 (0.164)
Day 2 0.065 (0.127) 0.033 (0.119) 0.170 (0.168)
Day 3 0 (ref.) 0 (ref.) 0 (ref.)






0.194 (0.093) 0.210 (0.118) 0.190 (0.083) 0.127 (0.060) 0.406 (0.177)
Within-subject
variance component (r2wY)
0.279 (0.043) 0.648 (0.098) 0.148 (0.023) 0.223 (0.035) 0.440 (0.069)
SE, standard error; NS, not significant; ref., reference group; U-Nap, urinary naphthalene; U-Phe, urinary phenanthrene; OH-Nap, sum of monohydroxylated metabolites of naphthalene; OH-Phe, sum
of monohydroxylated metabolites of phenanthrene; OH-Pyr, 1-hydroxypyrene; r2bY, between-person variance component (log scale); r
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been examined in workers exposed to hot asphalt
(Väänänen et al., 2003; McClean et al., 2004b;
Campo et al., 2006a,b; Väänänen et al., 2006; Buratti
et al., 2007), questions remain regarding the rates of
uptake and elimination for individual PAHs and the
influence that jobs, hydration level, and smoking sta-
tus might have on biomarker levels. To address these
questions, we applied linear models to levels of five
PAH biomarkers, measured in the urine of 26 road
construction workers using a repeated measures sam-
pling design (McClean et al., 2004a,b).
Urinary concentrations of U-Nap, U-Phe, OH-
Nap, OH-Phe, and OH-Pyr were comparable to those
reported in other occupational studies of asphalt
exposure (Campo et al., 2006a,b; Buratti et al.,
2007). Overall, OH-Nap was the most abundant uri-
nary analyte, followed by OH-Phe, OH-Pyr, U-Nap,
and finally U-Phe. Our results indicate that the con-
centration of U-Nap was 0.35% of OH-Nap, and that
the concentration of U-Phe was 0.85% of OH-Phe,
based upon the overall median values of these analy-
tes. These values are an about order of magnitude
lower than those observed in a previous study of coke
oven workers, where the mean levels of U-Nap and
U-Phe were 4 and 13%, respectively, of the corre-
sponding phenolic metabolite levels (Waidyanatha
et al., 2003). Since these coke oven workers are be-
lieved to have had higher exposures to Nap and
Phe than the asphalt workers in the current study
(Sobus et al., 2009), these results suggest that higher
amounts of unmetabolized Nap and Phe are excreted
in urine at elevated exposure levels. These observa-
tions may indicate metabolic saturation for Nap
and Phe in work environments where PAH levels
are particularly high. However, additional research
is needed to support this conjecture.
Overall, significant pairwise correlations between
analyte levels suggest common exposure sources
for Nap, Phe, and Pyr in paving and milling workers
(see Fig. 1). In baseline samples collected on the
Fig. 2. Estimated means of logged concentrations (ng l1) and 95% confidence intervals of urinary analytes measured among
paving workers at different times. Closed symbols represent paver operators, screedmen, and rakers; open symbols represent roller
operators. Urinary analytes: (A) naphthalene, (B) phenanthrene, (C) hydroxynaphthalene, (D) hydroxyphenanthrene,
(E) hydroxypyrene.
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morning of the first day of the workweek, no differ-
ences in analyte levels were observed between pavers
and millers. This indicates that PAHs arose from sim-
ilar background sources over the preceding weekend,
i.e., from the ambient environment and the diet, in
both groups of workers. No significant increase
above baseline levels was observed for any analyte
in the urine of the millers (see Table 1), as expected
because millers did not work with hot asphalt
(McClean et al., 2004a,b). For pavers, the largest de-
partures from baseline levels were observed in post-
shift samples (Table 1). A comparison of GM levels
showed that U-Phe was the most sensitive biomarker,
with postshift levels being 7-fold greater than base-
line levels; increases above baseline were 5-fold for
OH-Phe and OH-Pyr, 3-fold for U-Nap, and 2-fold
for OH-Nap.
Using linear mixed-effects models, we investi-
gated effects of time, hydration level (based on meas-
urements of urinary creatinine), work assignments,
workday, and smoking status on levels of PAH bio-
markers measured in postshift and bedtime urine
samples from the 20 paving workers. Results showed
that urinary creatinine was positively associated with
each urinary analyte (P-value ,0.0001), indicating
higher analyte concentrations with reduced urine vol-
ume (see Table 2). These results for U-Nap and U-
Phe were surprising, considering that unmetabolized
organic compounds tend to enter urine via diffusion
and, therefore, concentration should be independent
of urine output (Boeniger et al., 1993). Further re-
search is warranted to determine the effects of creat-
inine on levels of U-Nap and U-Phe relative to those
on OH-Nap, OH-Phe, and OH-Pyr. We note that the
final statistical models for each analyte were nearly
identical whether or not creatinine was included.
By including a fixed effect for time in our mod-
els, we were able to estimate elimination rate con-
stants for each analyte. We first examined work
assignment-specific elimination rates by including
a ‘time  assignment’ interaction term in each
model. Results showed that each model fit the data
well using a single elimination rate constant, suggest-
ing that analytes were eliminated at the same rate re-
gardless of the work assignment. The estimated T1/2
values and 95% confidence intervals were 7.70 h
(5.17 h, 15.1 h) for U-Phe, 10.2 h (7.07 h, 17.8 h)
for U-Nap, 13.3 h (7.79 h, 46.2 h) for OH-Pyr, 13.6
h (9.00 h, 27.7 h) for OH-Phe, and 25.7 h (14.1 h,
116 h) for OH-Nap. Although uncertainty was asso-
ciated with these estimates (as indicated by the 95%
confidence intervals), the unmetabolized compounds
(i.e. U-Nap and U-Phe) appeared to be eliminated
more quickly that the hydroxylated analytes; the
rapid removal of U-Nap and U-Phe from the body
has been observed elsewhere (Campo et al., 2007).
Slightly longer elimination half-lives were observed
for OH-Phe and OH-Pyr. The estimates for these
analytes (13 h) were very similar and were within
the range of estimates found in the literature for
OH-Pyr (4–48 h) (Jacob and Seidel, 2002; Brandt
and Watson, 2003; Hansen et al., 2008). While not
evaluated here, some assessments of the urinary ex-
cretion rate of OH-Pyr support a biphasic excretion
process, including a rapid phase of elimination
(hours), followed by a slower phase (days) (Heikkilä
et al., 1995; Buratti et al., 2007). Additional evidence
supports biphasic excretion of OH-Nap, with a very
rapid initial phase (1.2–1.9 h), followed by a slower
phase similar to that of OH-Pyr (14–46 h) (Heikkilä
et al., 1995). For this investigation, the estimate of
26 h for the half-life for OH-Nap is likely to be pos-
itively biased due to the highly significant effect of
smoking.
Considering the estimated elimination rates of the
PAH biomarkers in our study, we incorporated a fixed
effect for ‘workday’ into our models to investigate
bioaccumulation effects during consecutive work-
days. No workday effects were observed for U-Phe,
which had the shortest estimated elimination half-life
or for OH-Nap, which was highly affected by smok-
ing status. However, a significant workday effect was
observed for U-Nap, OH-Phe, and OH-Pyr. For each
analyte, levels were lowest on the first day of the
workweek and increased over workdays two and
three. While these significant workday effects point
to accumulation of analyte levels from previous
workdays, the contributions were relatively modest
in relation to those associated with exposures on
the current day (see Fig. 2).
After adjusting for time and workday effects,
a significant effect of work assignment was ob-
served for U-Nap, U-Phe, OH-Phe, and OH-Pyr
among paving workers, with roller operators having
the lowest urinary analyte levels. When roller oper-
ators were removed from the models, no significant
differences were observed for any analyte between
paver operators, screedmen, and rakers. Prior as-
sessments of this study population showed that the
rank order of exposures to PACs varied across work
assignments according to the exposure type (air
measurement or dermal patch measurement) and
in the case of dermal patch measurements, the
particular exposure surrogate (total dermal PACs
versus dermal Pyr) (McClean et al., 2004a,b). How-
ever, roller operators were shown to have experi-
enced both the lowest air levels (measured by both
total airborne PACs and airborne Pyr) and the lowest
dermal patch levels (measured by both total dermal
PACs and dermal Pyr) when compared to paver op-
erators, screedmen, and rakers. Since results of our
urinary biomarkers follow the same patterns, we
have evidence that U-Nap, U-Phe, OH-Phe, and
OH-Pyr are probably good surrogates for occupa-
tional exposure to PACs (including PAHs) in jobs
employing hot asphalt.
558 J. R. Sobus et al.
Results from the final model for OH-Nap indicate
that smoking status had a highly significant effect
on analyte levels. Similar effects of smoking on
OH-Nap have been observed in other studies of
asphalt-exposed workers (Väänänen et al., 2006;
Buratti et al., 2007). This smoking effect probably
explains the lower correlation coefficients for OH-
Nap compared to the other analytes (see Fig. 1).
After adjusting for the smoking effect, no significant
effect of work assignment was observed for OH-Nap
in contrast to U-Nap, U-Phe, OH-Phe, and OH-Pyr.
This effect of smoking reduces the utility of OH-
Nap as a measure of PAH exposure among asphalt-
exposed workers compared to the other urinary
biomarkers measured in our study.
Since Nap is present in cigarette smoke (Rustemeier
et al., 2002), an effect of smoking status on both OH-
Nap and U-Nap was expected. While a strong smok-
ing effect was observed for OH-Nap, no smoking
effect was observed for U-Nap (Table 2). Similar ob-
servations of the effects of smoking on OH-Nap and
U-Nap have been observed in studies of workers ex-
posed to jet fuel (JP-8) and coke oven emissions
(Serdar et al., 2003a,b; Waidyanatha et al., 2003).
Serdar et al. (2004) suggested that detoxification en-
zymes may be induced by cigarette smoke at low
Nap exposure levels, causing smokers to produce
higher levels of OH-Nap than nonsmokers at low
exposure levels and smokers to produce lower levels
of OH-Nap than nonsmokers at high exposure levels
(Serdar et al., 2004). A similar mechanism may
explain the inconsistencies observed between OH-
Nap and U-Nap in this study.
Levels of OH-Pyr in the urine have often been as-
sociated with smoking status in studies of PAH expo-
sure (Van Rooij et al., 1994; Hansen et al., 2008).
Moreover, the effects of smoking on OH-Pyr have
been demonstrated in studies of occupational expo-
sure to PAHs emanating from asphalt (Campo
et al., 2006b; Marczynski et al., 2006; Väänänen
et al., 2006; Buratti et al., 2007). In our analysis of
20 workers applying hot-mix asphalt, no smoking ef-
fect (P-value . 0.10) was observed for OH-Pyr after
adjusting for creatinine concentration, time of sam-
ple collection, work assignment, and workday. This
result was not entirely surprising, given that only
a marginal effect (P-value , 0.10) of smoking on
OH-Pyr was observed in a previous analysis of this
population, after adjusting for age, body mass index,
and inhalation and dermal Pyr exposure (McClean
et al., 2004b). The fact that milling workers (i.e.
workers that did not work with hot-mix asphalt) were
not included in our final statistical models may have
reduced our ability to observe a significant smoking
effect on OH-Pyr. Overall, the effects of smoking
on urinary biomarkers of PAH exposure, particularly
U-Nap, OH-Nap, and OH-Pyr, require further inves-
tigation, where PAH exposure levels (both through
inhalation and dermal routes) and smoking intensity
(rather than smoking status) are well characterized
for all study participants.
Results from this study indicate that U-Nap, U-
Phe, and OH-Phe, as well as the gold standard OH-
Pyr, are useful biomarkers of exposure to PAHs/
PACs emanating from hot asphalt sources. The short
half-lives of these analytes, which ranged from 8 to
14 h, indicate that urinary biomarker levels reflect
occupational exposures to PAHs in the short term
and suggest that representative samples should be
collected immediately after the workshift. The effect
of hydration level on analyte concentrations should
be carefully considered when analyzing biomarker
levels, even for unmetabolized PAHs in the urine,
which are predominantly eliminated by passive diffu-
sion. Significant differences in the levels of U-Nap,
U-Phe, OH-Phe, and OH-Pyr across work assign-
ments indicate that workers are differentially ex-
posed to PAHs during the workshift, depending on
the specific tasks that they perform; this information
should be considered in future assessments of health
risks for paving workers. Finally, our results indicate
that OH-Nap is not a useful PAH exposure bio-
marker, given the confounding effect of smoking,
and the lack of a work assignment effect on analyte
levels.
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